Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
about
Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug deliveryNanoparticulate adjuvants and delivery systems for allergen immunotherapyProtein corona - from molecular adsorption to physiological complexityNanotechnology: A Valuable Strategy to Improve Bacteriocin FormulationsAlkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140.Biocompatibility of chitosan carriers with application in drug delivery.Evaluation of mucoadhesive PLGA microparticles for nasal immunization.A polymer/oil based nanovaccine as a single-dose immunization approach.Enhanced immune response and protective effects of nano-chitosan-based DNA vaccine encoding T cell epitopes of Esat-6 and FL against Mycobacterium tuberculosis infection.Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice.Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model.Antitumor activity of peptide amphiphile nanofiber-encapsulated camptothecin.Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.Chitosan-based nanoparticles as a sustained protein release carrier for tissue engineering applicationsChitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide VaccinesNanoparticles as carriers for nasal vaccine delivery.The potential of chitosan for the oral administration of peptides.Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7.The performance of nanocarriers for transmucosal drug delivery.Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation.Nanoparticles and microparticles as vaccine-delivery systems.Nanoparticles as protein and gene carriers to mucosal surfaces.Nuclear delivery of recombinant OCT4 by chitosan nanoparticles for transgene-free generation of protein-induced pluripotent stem cells.Chitosan-based systems for the delivery of vaccine antigens.Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles.Chitosan-based delivery systems for mucosal vaccines.Nanomedicine in cardiovascular therapy: recent advancements.Intranasal formulations: promising strategy to deliver vaccines.Recent advances in vaccine delivery.Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: optimisation and cellular studies.Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.Construction of a smart microgel glutathione peroxidase mimic based on supramolecular self-assembly.Chitosan nanoparticles as a potential nonviral gene delivery for HPV-16 E7 into mammalian cells.Biopolymeric nanoparticles.Intranasal delivery of nanoparticle-based vaccines.Dry-powder form of chitosan nanospheres containing influenza virus and adjuvants for nasal immunization.Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin.
P2860
Q26748776-A6B2D839-2D48-447B-80F6-75F491944566Q26766552-0BEB30B2-FC05-468A-9261-73612B347E12Q26825418-0717614C-3789-4818-AF7C-118BD3B98850Q26853351-84B8834E-ABBE-457D-A3BC-595FFFBF8E38Q28077047-FA9783FB-48B7-467E-B60C-2E405F32A3A2Q30397973-84C7DC70-1621-4D0C-B229-56E06D4FAE10Q31076192-29B72E17-37DF-44AD-9BE9-4774872D2FD6Q33649839-EA753D6A-E1A1-47EE-B199-1320C2DB6566Q33749489-E39120FB-A70D-4770-8BD1-581A2B867E50Q34685874-86DED6B3-206F-4EAF-BD4E-70EE06184CE6Q34700107-7E0A7602-12A4-4F55-B799-47B8747191DCQ34956373-40B58002-E164-46E1-9636-492941779250Q35556928-DE7BF837-85A9-4A02-80EC-448B15B72222Q35588447-330D0DF2-8B78-42C6-B968-EE0A7B2EF97DQ35628183-0CEBFE45-49C3-4E6F-82B7-49C10EB6C3A1Q35783765-E659BF47-50CE-4A70-B3F3-E81296C9A270Q36101913-42625F94-8680-4BB8-A8C8-E737FE5F5123Q36124952-DC15107F-D4A5-4CBA-B4CF-7FBC3D8EB227Q36316822-BDBBBE7C-0B75-4615-9C1A-8644F36128A2Q36502198-A7059CCD-5689-4522-81AA-D286EDFF761DQ36527739-51D0CBA5-72E4-499C-9DD1-88F5DC74244CQ36941463-10B16CD4-7C9A-4B39-8615-8F34AD29374EQ36968297-4CE7661F-211F-4EE0-B495-1D656FC5D61AQ37331802-D696BEA3-C0C9-4BDE-8ED3-CBECA2C1EC39Q37437281-4CD6191E-A7F2-453F-9054-A0F43B83B4FAQ37524050-74EC22EE-EB12-4113-A4D4-A6D6C435F2E0Q37671847-46E0BAFE-0A33-465E-BF7E-817FC8A19418Q37766235-E199A081-22BD-4E07-B540-810C5875EEF7Q38019583-C4ADD48F-8008-4F9C-A580-8139F1801FDAQ38034812-CC8CA845-B113-4BBF-AD7A-3CABF4A0B56DQ38223050-5319920C-6850-4EB1-BABD-37CCD5ED23B6Q38669255-7048CE64-87D1-4A60-A2A1-D0ECF122D727Q38826782-556EBB02-AC7B-407C-BF69-F85B33549736Q38879581-11E52DC9-59A6-4F2A-AFC0-E6629E5E9124Q38998180-6D8165DF-0D74-4502-92F6-4A0855EA6C95Q39014313-C23274FC-F231-49AF-A269-526CAFDAA081Q39017307-1A6DB177-4672-4932-A637-323D50CFC177Q39113247-D6F9452D-DC59-4C90-82D3-84CF10C8EB95Q39169219-AB8DA2A7-9398-424A-8AD2-82C5D8A42815Q39711516-925E4295-F354-41A1-9037-CAC138133AFE
P2860
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Low molecular weight chitosan ...... asal vaccine delivery in mice.
@ast
Low molecular weight chitosan ...... asal vaccine delivery in mice.
@en
type
label
Low molecular weight chitosan ...... asal vaccine delivery in mice.
@ast
Low molecular weight chitosan ...... asal vaccine delivery in mice.
@en
prefLabel
Low molecular weight chitosan ...... asal vaccine delivery in mice.
@ast
Low molecular weight chitosan ...... asal vaccine delivery in mice.
@en
P2093
P50
P1476
Low molecular weight chitosan ...... asal vaccine delivery in mice.
@en
P2093
Alejandro Sánchez
Isabel Behrens
José Luis Vila Jato
María José Alonso
P304
P356
10.1016/J.EJPB.2003.09.006
P407
P577
2004-01-01T00:00:00Z